Global and United States Precision Cancer Diagnostic Tests Market Report & Forecast 2022-2028

SKU ID :QYR-20786816 | Published Date: 25-Apr-2022 | No. of pages: 117
1 Study Coverage 1.1 Precision Cancer Diagnostic Tests Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Introduction 1.2 Global Precision Cancer Diagnostic Tests Outlook 2017 VS 2022 VS 2028 1.2.1 Global Precision Cancer Diagnostic Tests Market Size for the Year 2017-2028 1.2.2 Global Precision Cancer Diagnostic Tests Market Size for the Year 2017-2028 1.3 Precision Cancer Diagnostic Tests Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Precision Cancer Diagnostic Tests in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Precision Cancer Diagnostic Tests Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Precision Cancer Diagnostic Tests Market Dynamics 1.4.1 Precision Cancer Diagnostic Tests Industry Trends 1.4.2 Precision Cancer Diagnostic Tests Market Drivers 1.4.3 Precision Cancer Diagnostic Tests Market Challenges 1.4.4 Precision Cancer Diagnostic Tests Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Precision Cancer Diagnostic Tests by Type 2.1 Precision Cancer Diagnostic Tests Market Segment by Type 2.1.1 Imaging 2.1.2 Molecular 2.1.3 Histology/Cytology 2.1.4 Tumor Marker Immunoassays 2.1.5 POC Colon Cancer Tests 2.2 Global Precision Cancer Diagnostic Tests Market Size by Type (2017, 2022 & 2028) 2.3 Global Precision Cancer Diagnostic Tests Market Size by Type (2017-2028) 2.4 United States Precision Cancer Diagnostic Tests Market Size by Type (2017, 2022 & 2028) 2.5 United States Precision Cancer Diagnostic Tests Market Size by Type (2017-2028) 3 Precision Cancer Diagnostic Tests by Application 3.1 Precision Cancer Diagnostic Tests Market Segment by Application 3.1.1 Hospital 3.1.2 Clinic 3.1.3 Other 3.2 Global Precision Cancer Diagnostic Tests Market Size by Application (2017, 2022 & 2028) 3.3 Global Precision Cancer Diagnostic Tests Market Size by Application (2017-2028) 3.4 United States Precision Cancer Diagnostic Tests Market Size by Application (2017, 2022 & 2028) 3.5 United States Precision Cancer Diagnostic Tests Market Size by Application (2017-2028) 4 Global Precision Cancer Diagnostic Tests Competitor Landscape by Company 4.1 Global Precision Cancer Diagnostic Tests Market Size by Company 4.1.1 Top Global Precision Cancer Diagnostic Tests Companies Ranked by Revenue (2021) 4.1.2 Global Precision Cancer Diagnostic Tests Revenue by Player (2017-2022) 4.2 Global Precision Cancer Diagnostic Tests Concentration Ratio (CR) 4.2.1 Precision Cancer Diagnostic Tests Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Precision Cancer Diagnostic Tests in 2021 4.2.3 Global Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Precision Cancer Diagnostic Tests Headquarters, Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Type 4.3.1 Global Precision Cancer Diagnostic Tests Headquarters and Area Served 4.3.2 Global Precision Cancer Diagnostic Tests Companies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Precision Cancer Diagnostic Tests Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Precision Cancer Diagnostic Tests Market Size by Company 4.5.1 Top Precision Cancer Diagnostic Tests Players in United States, Ranked by Revenue (2021) 4.5.2 United States Precision Cancer Diagnostic Tests Revenue by Players (2020, 2021 & 2022) 5 Global Precision Cancer Diagnostic Tests Market Size by Region 5.1 Global Precision Cancer Diagnostic Tests Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Precision Cancer Diagnostic Tests Market Size by Region (2017-2028) 5.2.1 Global Precision Cancer Diagnostic Tests Market Size by Region: 2017-2022 5.2.2 Global Precision Cancer Diagnostic Tests Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Precision Cancer Diagnostic Tests Market Size YoY Growth 2017-2028 6.1.2 North America Precision Cancer Diagnostic Tests Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Precision Cancer Diagnostic Tests Market Size YoY Growth 2017-2028 6.3.2 Europe Precision Cancer Diagnostic Tests Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Precision Cancer Diagnostic Tests Market Size YoY Growth 2017-2028 6.4.2 Latin America Precision Cancer Diagnostic Tests Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Precision Cancer Diagnostic Tests Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Precision Cancer Diagnostic Tests Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Abbott Laboratories 7.1.1 Abbott Laboratories Company Details 7.1.2 Abbott Laboratories Business Overview 7.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Introduction 7.1.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.1.5 Abbott Laboratories Recent Development 7.2 Agilent Technologies 7.2.1 Agilent Technologies Company Details 7.2.2 Agilent Technologies Business Overview 7.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Introduction 7.2.4 Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.2.5 Agilent Technologies Recent Development 7.3 Becton Dickinson and Company 7.3.1 Becton Dickinson and Company Company Details 7.3.2 Becton Dickinson and Company Business Overview 7.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Introduction 7.3.4 Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.3.5 Becton Dickinson and Company Recent Development 7.4 Bio-Rad Laboratories 7.4.1 Bio-Rad Laboratories Company Details 7.4.2 Bio-Rad Laboratories Business Overview 7.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Introduction 7.4.4 Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.4.5 Bio-Rad Laboratories Recent Development 7.5 Biocartis N.V. 7.5.1 Biocartis N.V. Company Details 7.5.2 Biocartis N.V. Business Overview 7.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Introduction 7.5.4 Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.5.5 Biocartis N.V. Recent Development 7.6 Biocept 7.6.1 Biocept Company Details 7.6.2 Biocept Business Overview 7.6.3 Biocept Precision Cancer Diagnostic Tests Introduction 7.6.4 Biocept Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.6.5 Biocept Recent Development 7.7 bioMerieux SA 7.7.1 bioMerieux SA Company Details 7.7.2 bioMerieux SA Business Overview 7.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Introduction 7.7.4 bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.7.5 bioMerieux SA Recent Development 7.8 Canon Medical Systems Corporation 7.8.1 Canon Medical Systems Corporation Company Details 7.8.2 Canon Medical Systems Corporation Business Overview 7.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Introduction 7.8.4 Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.8.5 Canon Medical Systems Corporation Recent Development 7.9 Cynvenio Biosystems 7.9.1 Cynvenio Biosystems Company Details 7.9.2 Cynvenio Biosystems Business Overview 7.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Introduction 7.9.4 Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.9.5 Cynvenio Biosystems Recent Development 7.10 Danaher Corporation 7.10.1 Danaher Corporation Company Details 7.10.2 Danaher Corporation Business Overview 7.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Introduction 7.10.4 Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.10.5 Danaher Corporation Recent Development 7.11 Epigenomics AG 7.11.1 Epigenomics AG Company Details 7.11.2 Epigenomics AG Business Overview 7.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Introduction 7.11.4 Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.11.5 Epigenomics AG Recent Development 7.12 Exosome Diagnostics 7.12.1 Exosome Diagnostics Company Details 7.12.2 Exosome Diagnostics Business Overview 7.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Introduction 7.12.4 Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.12.5 Exosome Diagnostics Recent Development 7.13 Foundation Medicine 7.13.1 Foundation Medicine Company Details 7.13.2 Foundation Medicine Business Overview 7.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Introduction 7.13.4 Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.13.5 Foundation Medicine Recent Development 7.14 General Electric Company 7.14.1 General Electric Company Company Details 7.14.2 General Electric Company Business Overview 7.14.3 General Electric Company Precision Cancer Diagnostic Tests Introduction 7.14.4 General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.14.5 General Electric Company Recent Development 7.15 Genomic Health 7.15.1 Genomic Health Company Details 7.15.2 Genomic Health Business Overview 7.15.3 Genomic Health Precision Cancer Diagnostic Tests Introduction 7.15.4 Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.15.5 Genomic Health Recent Development 7.16 Hologic 7.16.1 Hologic Company Details 7.16.2 Hologic Business Overview 7.16.3 Hologic Precision Cancer Diagnostic Tests Introduction 7.16.4 Hologic Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.16.5 Hologic Recent Development 7.17 Illumina 7.17.1 Illumina Company Details 7.17.2 Illumina Business Overview 7.17.3 Illumina Precision Cancer Diagnostic Tests Introduction 7.17.4 Illumina Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.17.5 Illumina Recent Development 7.18 Menarini Silicon Biosystems SpA 7.18.1 Menarini Silicon Biosystems SpA Company Details 7.18.2 Menarini Silicon Biosystems SpA Business Overview 7.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Introduction 7.18.4 Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.18.5 Menarini Silicon Biosystems SpA Recent Development 7.19 Myriad Genetics 7.19.1 Myriad Genetics Company Details 7.19.2 Myriad Genetics Business Overview 7.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Introduction 7.19.4 Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.19.5 Myriad Genetics Recent Development 7.20 NanoString Technologies 7.20.1 NanoString Technologies Company Details 7.20.2 NanoString Technologies Business Overview 7.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Introduction 7.20.4 NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.20.5 NanoString Technologies Recent Development 7.21 Ortho Clinical Diagnostics 7.21.1 Ortho Clinical Diagnostics Company Details 7.21.2 Ortho Clinical Diagnostics Business Overview 7.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Introduction 7.21.4 Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.21.5 Ortho Clinical Diagnostics Recent Development 7.22 QIAGEN N.V. 7.22.1 QIAGEN N.V. Company Details 7.22.2 QIAGEN N.V. Business Overview 7.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Introduction 7.22.4 QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.22.5 QIAGEN N.V. Recent Development 7.23 Randox Laboratories Ltd. 7.23.1 Randox Laboratories Ltd. Company Details 7.23.2 Randox Laboratories Ltd. Business Overview 7.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Introduction 7.23.4 Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.23.5 Randox Laboratories Ltd. Recent Development 7.24 Roche Holding AG 7.24.1 Roche Holding AG Company Details 7.24.2 Roche Holding AG Business Overview 7.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Introduction 7.24.4 Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.24.5 Roche Holding AG Recent Development 7.25 Royal Philips N.V. 7.25.1 Royal Philips N.V. Company Details 7.25.2 Royal Philips N.V. Business Overview 7.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Introduction 7.25.4 Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.25.5 Royal Philips N.V. Recent Development 7.26 Siemens AG 7.26.1 Siemens AG Company Details 7.26.2 Siemens AG Business Overview 7.26.3 Siemens AG Precision Cancer Diagnostic Tests Introduction 7.26.4 Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.26.5 Siemens AG Recent Development 7.27 Thermo Fisher Scientific 7.27.1 Thermo Fisher Scientific Company Details 7.27.2 Thermo Fisher Scientific Business Overview 7.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Introduction 7.27.4 Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.27.5 Thermo Fisher Scientific Recent Development 7.28 Vela Diagnostics 7.28.1 Vela Diagnostics Company Details 7.28.2 Vela Diagnostics Business Overview 7.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Introduction 7.28.4 Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) 7.28.5 Vela Diagnostics Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer
List of Tables Table 1. Precision Cancer Diagnostic Tests Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Precision Cancer Diagnostic Tests Market Trends Table 3. Precision Cancer Diagnostic Tests Market Drivers Table 4. Precision Cancer Diagnostic Tests Market Challenges Table 5. Precision Cancer Diagnostic Tests Market Restraints Table 6. Global Precision Cancer Diagnostic Tests Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Precision Cancer Diagnostic Tests Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Precision Cancer Diagnostic Tests Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Precision Cancer Diagnostic Tests Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Precision Cancer Diagnostic Tests Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Precision Cancer Diagnostic Tests Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Precision Cancer Diagnostic Tests Revenue Share by Player, 2017-2022 Table 13. Global Precision Cancer Diagnostic Tests Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Precision Cancer Diagnostic Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2021) Table 15. Top Players of Precision Cancer Diagnostic Tests in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Precision Cancer Diagnostic Tests Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Precision Cancer Diagnostic Tests Players in United States Market, Ranking by Revenue (2021) Table 20. United States Precision Cancer Diagnostic Tests Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Precision Cancer Diagnostic Tests Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Precision Cancer Diagnostic Tests Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Precision Cancer Diagnostic Tests Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Precision Cancer Diagnostic Tests Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Precision Cancer Diagnostic Tests Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Precision Cancer Diagnostic Tests Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Precision Cancer Diagnostic Tests Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Precision Cancer Diagnostic Tests Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Precision Cancer Diagnostic Tests Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Abbott Laboratories Company Details Table 31. Abbott Laboratories Business Overview Table 32. Abbott Laboratories Precision Cancer Diagnostic Tests Product Table 33. Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 34. Abbott Laboratories Recent Development Table 35. Agilent Technologies Company Details Table 36. Agilent Technologies Business Overview Table 37. Agilent Technologies Precision Cancer Diagnostic Tests Product Table 38. Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 39. Agilent Technologies Recent Development Table 40. Becton Dickinson and Company Company Details Table 41. Becton Dickinson and Company Business Overview Table 42. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Table 43. Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 44. Becton Dickinson and Company Recent Development Table 45. Bio-Rad Laboratories Company Details Table 46. Bio-Rad Laboratories Business Overview Table 47. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Table 48. Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 49. Bio-Rad Laboratories Recent Development Table 50. Biocartis N.V. Company Details Table 51. Biocartis N.V. Business Overview Table 52. Biocartis N.V. Precision Cancer Diagnostic Tests Product Table 53. Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 54. Biocartis N.V. Recent Development Table 55. Biocept Company Details Table 56. Biocept Business Overview Table 57. Biocept Precision Cancer Diagnostic Tests Product Table 58. Biocept Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 59. Biocept Recent Development Table 60. bioMerieux SA Company Details Table 61. bioMerieux SA Business Overview Table 62. bioMerieux SA Precision Cancer Diagnostic Tests Product Table 63. bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 64. bioMerieux SA Recent Development Table 65. Canon Medical Systems Corporation Company Details Table 66. Canon Medical Systems Corporation Business Overview Table 67. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Table 68. Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 69. Canon Medical Systems Corporation Recent Development Table 70. Cynvenio Biosystems Company Details Table 71. Cynvenio Biosystems Business Overview Table 72. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Table 73. Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 74. Cynvenio Biosystems Recent Development Table 75. Danaher Corporation Company Details Table 76. Danaher Corporation Business Overview Table 77. Danaher Corporation Precision Cancer Diagnostic Tests Product Table 78. Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 79. Danaher Corporation Recent Development Table 80. Epigenomics AG Company Details Table 81. Epigenomics AG Business Overview Table 82. Epigenomics AG Precision Cancer Diagnostic Tests Product Table 83. Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 84. Epigenomics AG Recent Development Table 85. Exosome Diagnostics Company Details Table 86. Exosome Diagnostics Business Overview Table 87. Exosome Diagnostics Precision Cancer Diagnostic Tests Product Table 88. Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 89. Exosome Diagnostics Recent Development Table 90. Foundation Medicine Company Details Table 91. Foundation Medicine Business Overview Table 92. Foundation Medicine Precision Cancer Diagnostic Tests Product Table 93. Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 94. Foundation Medicine Recent Development Table 95. General Electric Company Company Details Table 96. General Electric Company Business Overview Table 97. General Electric Company Precision Cancer Diagnostic Tests Product Table 98. General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 99. General Electric Company Recent Development Table 100. Genomic Health Company Details Table 101. Genomic Health Business Overview Table 102. Genomic Health Precision Cancer Diagnostic Tests Product Table 103. Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 104. Genomic Health Recent Development Table 105. Hologic Company Details Table 106. Hologic Business Overview Table 107. Hologic Precision Cancer Diagnostic Tests Product Table 108. Hologic Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 109. Hologic Recent Development Table 110. Illumina Company Details Table 111. Illumina Business Overview Table 112. Illumina Precision Cancer Diagnostic Tests Product Table 113. Illumina Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 114. Illumina Recent Development Table 115. Menarini Silicon Biosystems SpA Company Details Table 116. Menarini Silicon Biosystems SpA Business Overview Table 117. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Table 118. Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 119. Menarini Silicon Biosystems SpA Recent Development Table 120. Myriad Genetics Company Details Table 121. Myriad Genetics Business Overview Table 122. Myriad Genetics Precision Cancer Diagnostic Tests Product Table 123. Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 124. Myriad Genetics Recent Development Table 125. NanoString Technologies Company Details Table 126. NanoString Technologies Business Overview Table 127. NanoString Technologies Precision Cancer Diagnostic Tests Product Table 128. NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 129. NanoString Technologies Recent Development Table 130. Ortho Clinical Diagnostics Company Details Table 131. Ortho Clinical Diagnostics Business Overview Table 132. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Table 133. Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 134. Ortho Clinical Diagnostics Recent Development Table 135. QIAGEN N.V. Company Details Table 136. QIAGEN N.V. Business Overview Table 137. QIAGEN N.V. Precision Cancer Diagnostic Tests Product Table 138. QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 139. QIAGEN N.V. Recent Development Table 140. Randox Laboratories Ltd. Company Details Table 141. Randox Laboratories Ltd. Business Overview Table 142. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Table 143. Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 144. Randox Laboratories Ltd. Recent Development Table 145. Roche Holding AG Company Details Table 146. Roche Holding AG Business Overview Table 147. Roche Holding AG Precision Cancer Diagnostic Tests Product Table 148. Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 149. Roche Holding AG Recent Development Table 150. Royal Philips N.V. Company Details Table 151. Royal Philips N.V. Business Overview Table 152. Royal Philips N.V. Precision Cancer Diagnostic Tests Product Table 153. Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 154. Royal Philips N.V. Recent Development Table 155. Siemens AG Company Details Table 156. Siemens AG Business Overview Table 157. Siemens AG Precision Cancer Diagnostic Tests Product Table 158. Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 159. Siemens AG Recent Development Table 160. Thermo Fisher Scientific Company Details Table 161. Thermo Fisher Scientific Business Overview Table 162. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Table 163. Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 164. Thermo Fisher Scientific Recent Development Table 165. Vela Diagnostics Company Details Table 166. Vela Diagnostics Business Overview Table 167. Vela Diagnostics Precision Cancer Diagnostic Tests Product Table 168. Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million) Table 169. Vela Diagnostics Recent Development Table 170. Research Programs/Design for This Report Table 171. Key Data Information from Secondary Sources Table 172. Key Data Information from Primary Sources List of Figures Figure 1. Precision Cancer Diagnostic Tests Product Picture Figure 2. Global Precision Cancer Diagnostic Tests Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Precision Cancer Diagnostic Tests Market Size 2017-2028 (US$ Million) Figure 4. United States Precision Cancer Diagnostic Tests Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Precision Cancer Diagnostic Tests Market Size 2017-2028 (US$ Million) Figure 6. United States Precision Cancer Diagnostic Tests Market Share in Global 2017-2028 Figure 7. Precision Cancer Diagnostic Tests Report Years Considered Figure 8. Product Picture of Imaging Figure 9. Product Picture of Molecular Figure 10. Product Picture of Histology/Cytology Figure 11. Product Picture of Tumor Marker Immunoassays Figure 12. Product Picture of POC Colon Cancer Tests Figure 13. Global Precision Cancer Diagnostic Tests Market Share by Type in 2022 & 2028 Figure 14. Global Precision Cancer Diagnostic Tests Market Size by Type (2017-2028) & (US$ Million) Figure 15. Global Precision Cancer Diagnostic Tests Market Share by Type (2017-2028) Figure 16. United States Precision Cancer Diagnostic Tests Market Share by Type in 2022 & 2028 Figure 17. United States Precision Cancer Diagnostic Tests Market Size by Type (2017-2028) & (US$ Million) Figure 18. United States Precision Cancer Diagnostic Tests Market Share by Type (2017-2028) Figure 19. Product Picture of Hospital Figure 20. Product Picture of Clinic Figure 21. Product Picture of Other Figure 22. Global Precision Cancer Diagnostic Tests Market Share by Application in 2022 & 2028 Figure 23. Global Precision Cancer Diagnostic Tests Market Size by Application (2017-2028) & (US$ Million) Figure 24. Global Precision Cancer Diagnostic Tests Market Share by Application (2017-2028) Figure 25. United States Precision Cancer Diagnostic Tests Market Share by Application in 2022 & 2028 Figure 26. United States Precision Cancer Diagnostic Tests Market Size by Application (2017-2028) & (US$ Million) Figure 27. United States Precision Cancer Diagnostic Tests Market Share by Application (2017-2028) Figure 28. North America Precision Cancer Diagnostic Tests Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. U.S. Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Canada Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Europe Precision Cancer Diagnostic Tests Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. Germany Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. France Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. U.K. Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Italy Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Russia Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Asia-Pacific Precision Cancer Diagnostic Tests Market Size Growth Rate 2017-2028 (US$ Million) Figure 38. China Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Japan Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. South Korea Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. India Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Australia Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Taiwan Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Indonesia Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Thailand Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Malaysia Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Philippines Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Latin America Precision Cancer Diagnostic Tests Market Size Growth Rate 2017-2028 (US$ Million) Figure 49. Mexico Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Brazil Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Argentina Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Middle East & Africa Precision Cancer Diagnostic Tests Market Size Growth Rate 2017-2028 (US$ Million) Figure 53. Turkey Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. U.A.E Precision Cancer Diagnostic Tests Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. Abbott Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 57. Agilent Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 58. Becton Dickinson and Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 60. Biocartis N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 61. Biocept Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 62. bioMerieux SA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 63. Canon Medical Systems Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 64. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 65. Danaher Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 66. Epigenomics AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 67. Exosome Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 68. Foundation Medicine Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 69. General Electric Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 70. Genomic Health Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 71. Hologic Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 72. Illumina Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 73. Menarini Silicon Biosystems SpA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 74. Myriad Genetics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 75. NanoString Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 76. Ortho Clinical Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 77. QIAGEN N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 78. Randox Laboratories Ltd. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 79. Roche Holding AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 80. Royal Philips N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 81. Siemens AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 82. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 83. Vela Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022) Figure 84. Bottom-up and Top-down Approaches for This Report Figure 85. Data Triangulation Figure 86. Key Executives Interviewed
Abbott Laboratories Agilent Technologies Becton Dickinson and Company Bio-Rad Laboratories Biocartis N.V. Biocept bioMerieux SA Canon Medical Systems Corporation Cynvenio Biosystems Danaher Corporation Epigenomics AG Exosome Diagnostics Foundation Medicine General Electric Company Genomic Health Hologic Illumina Menarini Silicon Biosystems SpA Myriad Genetics NanoString Technologies Ortho Clinical Diagnostics QIAGEN N.V. Randox Laboratories Ltd. Roche Holding AG Royal Philips N.V. Siemens AG Thermo Fisher Scientific Vela Diagnostics
  • PRICE
  • $4350
    $8700
    $5075
    Buy Now

Our Clients